COMMUNIQUÉS West-GlobeNewswire

Vericel Reports Fourth Quarter and Year End 2017 Financial Results and Provides Full Year 2018 Financial Guidance
05/03/2018
Record Quarterly Revenues of $23.4 Million Represent a 41% Increase Over Fourth Quarter 2016 Positive Operating and Net Income Reported for the Fourth Quarter Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass [...]
Conatus Pharmaceuticals to Highlight Anticipated Clinical Data Readouts at Upcoming Investor Conferences
05/03/2018
SAN DIEGO, March 05, 2018 (GLOBE NEWSWIRE) -- At three upcoming investor conferences in March, Conatus Pharmaceuticals Inc. (NASDAQ: CNAT ) President, Chief Executive Officer and co-founder, Steven J. Mento, Ph.D., and [...]
Actinium Announces $15.4 Million in Expected Gross Proceeds from Recently Expired Rights Offering
05/03/2018
NEW YORK, March 05, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company") announced today that the Company’s previously announced rights offering (“the Rights [...]
Zealand Pharma to present at the Cowen & Co. Health Care Conference, March 12, 2018 in Boston
05/03/2018
Press release - No. 06 / 2018 Zealand Pharma to present at the Cowen & Co. Health Care Conference, March 12, 2018 in Boston Copenhagen, March 5, 2018 - Britt Meelby Jensen, President and Chief Executive Officer (CEO [...]
Biohit Oyj - Managers' Transactions
05/03/2018
Biohit Oyj - Managers' Transactions, March 5, 2018 at 2:10 pm local time (EEST) Biohit Oyj has received the following notification. Biohit Oyj - Managers' Transactions ____________________________________________ Person [...]
Agios to Present at the Cowen 38th Annual Healthcare Conference Monday, March 12, 2018
05/03/2018
CAMBRIDGE, Mass., March 05, 2018 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (NASDAQ: AGIO ), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today announced that the company [...]
SHIRE LAUNCHES MYPKFIT(TM) FOR ADVATE® [ANTIHEMOPHILIC FACTOR (RECOMBINANT)] IN THE U.S.
05/03/2018
SHIRE LAUNCHES MYPKFIT (TM) FOR ADVATE ® [ANTIHEMOPHILIC FACTOR (RECOMBINANT)] IN THE U.S. First and only FDA-cleared PK dosing software now available to help healthcare professionals create personalized treatment [...]
Horizon Discovery hosts Capital Markets Day today
05/03/2018
Horizon Discovery Group plc Horizon Discovery hosts Capital Markets Day today Cambridge, UK, 5 March 2018: Horizon Discovery Group plc (LSE: HZD) ("Horizon" or "the Group"), a global leader in gene editing and gene [...]
BioDelivery Sciences to Present at the 30th Annual ROTH Conference
05/03/2018
RALEIGH, N.C., March 05, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ), a specialty pharmaceutical company with a focus in pain management and addiction medicine, today announced that [...]
Lexington Cardiovascular Health Monitor Performing as Designed with First Clinical Patients
05/03/2018
VANCOUVER, British Columbia, March 05, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is pleased to provide an [...]
Medibio signs binding term sheet to acquire Vital Conversations
05/03/2018
Capitalizes on 3 years of partnership success in Corporate Health programs Appoints Peta Slocombe, founder of Australia’s Biggest Mental Health Check-In, to lead Medibio Corporate Health Strategic Business Unit [...]
Ossur Hf : Candidates to the Board of Directors
05/03/2018
Announcement no. 14/2018 Reykjavik, 5 March 2018 Candidates to the Board of Directors Enclosed details on the candidates to the Board of Directors of Össur hf., to be elected at the Company's Annual General Meeting held [...]
Santhera Reports Outcome of Exploratory Trial with Idebenone in PPMS Conducted at the NIH
05/03/2018
Pratteln, Switzerland, March 5, 2018 - Santhera Pharmaceuticals (SIX: SANN) announces that the exploratory Phase I/II clinical trial in primary progressive multiple sclerosis (PPMS) conducted as an investigator- [...]
Addex Secures Investor Commitment for CHF40 million Capital Increase Following Successful Completion of Book Building Process
05/03/2018
Geneva, Switzerland, 5 March 2018 - Addex Therapeutics (SIX: ADXN), the leading developer of oral allosteric modulators for neurological disorders, announced today that the Company has secured investor commitments for [...]
Immutep receives A$686,704 R&D Tax Incentive
05/03/2018
SYDNEY, Australia, March 04, 2018 (GLOBE NEWSWIRE) -- Immutep Limited (ASX:IMM) (NASDAQ: IMMP ) (“Immutep” or the “Company”), is pleased to announce that it has received a A$686,704 cash rebate from the Australian [...]
Onconova Announces Presentation of Mechanism of Action Studies of Rigosertib Combination with Azacitidine at American Association for Cancer Research (AACR) Epigenetics Conference
04/03/2018
Effect of rigosertib plus azacitidine treatment on epigenetic modulation in cancer cell-lines and patient derived bone marrow cells Study suggests potential novel clinical strategies to improve outcomes for patients [...]
New Data from Pivotal Phase 3 Study Investigating Lanadelumab as a Prophylactic Treatment for HAE to be Presented at 2018 AAAAI/WAO Joint Congress
03/03/2018
New Data from Pivotal Phase 3 Study Investigating Lanadelumab as a Prophylactic Treatment for Hereditary Angioedema to be Presented at 2018 AAAAI/WAO Joint Congress - Data from the largest prevention study in HAE [...]
Flexion Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
02/03/2018
BURLINGTON, Mass., March 02, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq: FLXN ) today announced a grant of inducement stock options to two new employees for an aggregate of 4,000 shares of common stock [...]
Molecular Templates Closes $10 Million Debt Facility with Perceptive Advisors
02/03/2018
AUSTIN, Texas, March 02, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq: MTEM ) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new [...]

Pages